| Literature DB >> 33573162 |
Francesco Sabbatino1,2, Valeria Conti1,3, Luigi Liguori4, Giovanna Polcaro1, Graziamaria Corbi5, Valentina Manzo1,3, Vincenzo Tortora4, Chiara Carlomagno4, Carmine Vecchione1,6, Amelia Filippelli1,3, Stefano Pepe1,2.
Abstract
Reactive oxygen species (ROS) are molecules involved in signal transduction pathways with both beneficial and detrimental effects on human cells. ROS are generated by many cellular processes including mitochondrial respiration, metabolism and enzymatic activities. In physiological conditions, ROS levels are well-balanced by antioxidative detoxification systems. In contrast, in pathological conditions such as cardiovascular, neurological and cancer diseases, ROS production exceeds the antioxidative detoxification capacity of cells, leading to cellular damages and death. In this review, we will first describe the biology and mechanisms of ROS mediated oxidative stress in cardiovascular disease. Second, we will review the role of oxidative stress mediated by oncological treatments in inducing cardiovascular disease. Lastly, we will discuss the strategies that potentially counteract the oxidative stress in order to fight the onset and progression of cardiovascular disease, including that induced by oncological treatments.Entities:
Keywords: ROS; antioxidative treatment; cardiotoxicity; cardiovascular disease; endothelial dysfunction; oncological treatments; oxidative stress
Year: 2021 PMID: 33573162 PMCID: PMC7911715 DOI: 10.3390/life11020105
Source DB: PubMed Journal: Life (Basel) ISSN: 2075-1729